Abigail L B Snow, Abagail E Ciriegio, Kelly H Watson, Mary G Baumann, Anna C Pfalzer, Spencer Diehl, Kathleen Duncan, Katherine E McDonell, Daniel O Claassen, Bruce E Compas
Background: Huntington's disease (HD) presents patients and individuals at risk for HD with significant levels of stress. However, relatively little research has examined how individuals cope with stress related to the disease or the association of specific coping strategies with psychological symptoms.
Objective: This study examined the ways in which HD patients and at-risk individuals cope with HD-related stress using a control-based model of coping and the association of coping strategies with symptoms of depression and anxiety.
Methods: HD patients (n = 49) and at-risk individuals (n = 76) completed the Responses to Stress Questionnaire - Huntington's Disease Version to assess coping strategies in response to HD-related stress, as well as standardized measures of depression and anxiety symptoms. Patient health records were accessed to obtain information related to disease characteristics.
Results: Patients and at-risk individuals reported using comparable levels of primary control coping, secondary control coping, and disengagement coping strategies. In linear regression analyses, only secondary control coping was significantly associated with lower depression (β= -0.62, p < 0.001) and anxiety (β= -0.59, p < 0.001) symptoms in patients and at-risk individuals (β= -0.55, p < 0.001 and β= -0.50, p < 0.001, respectively).
Conclusions: Secondary control coping may be beneficial for both HD patients and at-risk individuals. Future research using the control-based model of coping in longitudinal studies with the HD population is needed, and future interventions could test the effects of cognitive reframing and acceptance as coping strategies for families affected by HD.
J Huntingtons Dis. 2023;12(3):305-312
[PMID:
37334612]
J Consult Clin Psychol. 1994 Apr;62(2):324-32
[PMID:
8201070]
J Neuropsychiatry Clin Neurosci. 2021 Fall;33(4):321-327
[PMID:
34280320]
Lancet Neurol. 2013 Jul;12(7):637-49
[PMID:
23664844]
J Huntingtons Dis. 2024;13(2):215-224
[PMID:
38578897]
Psychosomatics. 2012 May-Jun;53(3):220-9
[PMID:
22458993]
J Neurol. 2024 Jan;271(1):289-299
[PMID:
37695532]
Arch Psychiatr Nurs. 2021 Jun;35(3):284-289
[PMID:
33966794]
Neuropsychology. 2020 Aug 06;:
[PMID:
32757576]
J Neuropsychiatry Clin Neurosci. 2015 Fall;27(4):262-71
[PMID:
25803201]
Nat Rev Dis Primers. 2015 Apr 23;1:15005
[PMID:
27188817]
Psychol Health Med. 2014;19(2):169-79
[PMID:
23767964]
Br J Health Psychol. 2002 Nov;7(Part 4):449-462
[PMID:
12614496]
J Consult Clin Psychol. 2000 Dec;68(6):976-92
[PMID:
11142550]
J Biomed Inform. 2009 Apr;42(2):377-81
[PMID:
18929686]
Arch Intern Med. 2006 May 22;166(10):1092-7
[PMID:
16717171]
J Huntingtons Dis. 2018;7(3):355-366
[PMID:
30040737]
Int Rev Neurobiol. 2011;98:297-323
[PMID:
21907093]
Am J Psychiatry. 2016 Feb 1;173(2):184-92
[PMID:
26472629]
J Neuropsychiatry Clin Neurosci. 2012 Winter;24(1):53-60
[PMID:
22450614]
J Pers Med. 2022 Jan 07;12(1):
[PMID:
35055379]
J Neuropsychiatry Clin Neurosci. 2020 Spring;32(2):109-124
[PMID:
31466515]
Clin Genet. 2007 Feb;71(2):120-9
[PMID:
17250660]
Psychol Bull. 2017 Sep;143(9):939-991
[PMID:
28616996]
Neuropsychology. 2022 May;36(4):288-296
[PMID:
35201782]
J Consult Clin Psychol. 2006 Dec;74(6):1132-42
[PMID:
17154742]
Cognit Ther Res. 2013 Feb;37(1):
[PMID:
24244057]
J Gen Intern Med. 2001 Sep;16(9):606-13
[PMID:
11556941]
Psychooncology. 2006 Dec;15(12):1038-54
[PMID:
17009343]
J Huntingtons Dis. 2019;8(4):467-482
[PMID:
31424415]
Humans
Huntington Disease
Adaptation, Psychological
Male
Female
Middle Aged
Adult
Depression
Anxiety
Stress, Psychological
Surveys and Questionnaires
